Literature DB >> 8517688

Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.

S Y Tsui1, W W Yew, M S Li, C Y Chan, A F Cheng.   

Abstract

A study of postantibiotic effects (PAE) in vitro of amikacin and ofloxacin on Mycobacterium fortuitum isolates from sternotomy wounds by use of the dilution method for drug removal showed that both drugs exhibited good bactericidal activities, with the PAE of amikacin lasting from 13.5 to 27.6 h and the PAE of ofloxacin lasting from 1.2 to 5.0 h. These laboratory results concur with our experience of the efficacy of once-daily dosing with these drugs in the treatment of infections caused by M. fortuitum. These data may have therapeutic implications in guiding the scheduling of the administration of drugs in these infections, which require a long duration of therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8517688      PMCID: PMC187877          DOI: 10.1128/AAC.37.5.1001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  Postantibiotic effects.

Authors:  B S Vogelman; W A Craig
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

3.  Postantibiotic suppression of bacterial growth.

Authors:  R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

4.  Observations in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosis.

Authors:  J M Dickinson; D A Mitchison
Journal:  Tubercle       Date:  1970-12

5.  Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.

Authors:  L S Young; O G Berlin; C B Inderlied
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

6.  Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.

Authors:  P J McDonald; W A Craig; C M Kunin
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

7.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.

Authors:  J M Swenson; R J Wallace; V A Silcox; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

8.  Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.

Authors:  D F Welch; M T Kelly
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

9.  Dosage schedules of antimicrobial agents: a historical review.

Authors:  C M Kunin
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

10.  In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.

Authors:  J R Dalovisio; G A Pankey
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

View more
  5 in total

1.  Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.

Authors:  L Licata; C E Smith; R M Goldschmidt; J F Barrett; M Frosco
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 2.  The role of fluoroquinolones in tuberculosis today.

Authors:  S E Berning
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Comparison of CO2 generation (BACTEC) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complex.

Authors:  G G Zhanel; M H Saunders; J N Wolfe; D J Hoban; J A Karlowsky; A M Kabani
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

4.  Postantibiotic effects of antituberculosis agents alone and in combination.

Authors:  C Y Chan; C Au-Yeang; W W Yew; M Hui; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex.

Authors:  L C Ellis; C A Benson; G I Koenig; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.